Fibromyalgia Trial, Recruiting NCT06368492 Sponsor: Maastricht University Condition: Fibromyalgia
Back to Fibromyalgia

Fibromyalgia Trial, Recruiting

NCT06368492
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 18 and 65 years old
  • Your weight is in a healthy range, with a BMI (body mass index) between 18 and 28
  • You have been diagnosed with fibromyalgia according to recognised medical guidelines
  • Your pain level is at least 5 out of 10 on a standard pain scale
  • You can speak and read Dutch or English well enough to understand the study
  • You are willing to sign a consent form confirming you understand what the study involves and its risks
  • You do not regularly take strong medications such as opioids, antidepressants, muscle relaxants, anti-seizure drugs, sleeping pills, or benzodiazepines — though some common over-the-counter pain relief (such as paracetamol or ibuprofen within certain daily limits) is allowed
  • You are willing to avoid taking any mind-altering substances during the study
  • You are willing to avoid alcohol, coffee, tea, and energy drinks from midnight before each study session and throughout each study day
  • You are willing not to drive or operate heavy machinery for 24 hours after receiving the study substance

Who may not be able to join:

  • You have another painful condition, such as inflammatory joint disease, migraines, or other ongoing or recent serious health conditions
  • You have, or have had, another mental health condition such as major depression, an anxiety disorder, or a substance use disorder, as assessed through questionnaires and a medical check
  • You have previously had a serious bad reaction to psychedelic drugs, such as severe anxiety or panic attacks
  • You smoke more than 20 cigarettes per day
  • You drink more than 20 alcoholic drinks per week
  • A close blood relative (parent, sibling, or child) has been diagnosed with a psychotic disorder
  • You are pregnant or breastfeeding
  • You have high blood pressure (above 140/90 mmHg)
  • You have a history of heart problems, such as irregular heartbeat or heart disease
  • You are a woman who is not using a reliable form of contraception (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Johannes G. Ramaekers, PhD, Maastricht University

Phone: ‭+310683029784‬

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Maastricht University
Registry
ClinicalTrials.gov
Start date
3 May 2024
Est. completion
1 December 2025

Where this trial is recruiting

🇳🇱 Netherlands

Primary endpoints

Ischemic Pain perception; Pressure-evoked Pain perception; Self-reported pain

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov